Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lantus vs Humalog Mix 75/25 in T2DM Patients Failing Oral Therapy
NCT01336751Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2001
- Primary completion
- Dec 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jul 2001; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01336751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336751.